These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21499268)

  • 21. GIT1 mediates thrombin signaling in endothelial cells: role in turnover of RhoA-type focal adhesions.
    van Nieuw Amerongen GP; Natarajan K; Yin G; Hoefen RJ; Osawa M; Haendeler J; Ridley AJ; Fujiwara K; van Hinsbergh VW; Berk BC
    Circ Res; 2004 Apr; 94(8):1041-9. PubMed ID: 15016733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.
    Mergy MA; Gowrishankar R; Davis GL; Jessen TN; Wright J; Stanwood GD; Hahn MK; Blakely RD
    Neurochem Int; 2014 Jul; 73():56-70. PubMed ID: 24332984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse.
    Siesser WB; Cheng SY; McDonald MP
    Psychopharmacology (Berl); 2005 Oct; 181(4):653-63. PubMed ID: 15983791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microcephaly with altered cortical layering in GIT1 deficiency revealed by quantitative neuroimaging.
    Badea A; Schmalzigaug R; Kim W; Bonner P; Ahmed U; Johnson GA; Cofer G; Foster M; Anderson RJ; Badea C; Premont RT
    Magn Reson Imaging; 2021 Feb; 76():26-38. PubMed ID: 33010377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice.
    Menon P; Deane R; Sagare A; Lane SM; Zarcone TJ; O'Dell MR; Yan C; Zlokovic BV; Berk BC
    Brain Res; 2010 Mar; 1317():218-26. PubMed ID: 20043896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of transmembrane AMPA receptor regulatory protein γ-8 leads to attention-deficit hyperactivity disorder-like behavior in mice.
    Bai WJ; Luo XG; Jin BH; Zhu KS; Guo WY; Zhu XQ; Qin X; Yang ZX; Zhao JJ; Chen SR; Wang R; Hao J; Wang F; Shi YS; Kong DZ; Zhang W
    Zool Res; 2022 Sep; 43(5):851-870. PubMed ID: 36031768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass.
    Menon P; Yin G; Smolock EM; Zuscik MJ; Yan C; Berk BC
    J Cell Physiol; 2010 Nov; 225(3):777-85. PubMed ID: 20568227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
    Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
    Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate.
    Keck TM; Suchland KL; Jimenez CC; Grandy DK
    Pharmacol Biochem Behav; 2013 Feb; 103(4):831-41. PubMed ID: 23262298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
    Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
    Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.
    Kirley A; Lowe N; Hawi Z; Mullins C; Daly G; Waldman I; McCarron M; O'Donnell D; Fitzgerald M; Gill M
    Am J Med Genet B Neuropsychiatr Genet; 2003 Aug; 121B(1):50-4. PubMed ID: 12898575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val⁶⁶Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children.
    Kim BN; Cummins TD; Kim JW; Bellgrove MA; Hong SB; Song SH; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1399-410. PubMed ID: 21733227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
    Gerlach M; Grünblatt E; Lange KW
    Atten Defic Hyperact Disord; 2013 Jun; 5(2):71-81. PubMed ID: 23605387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
    Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
    Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta band oscillatory deficits during working memory encoding in adolescents with attention-deficit hyperactive disorder.
    Zammit N; Muscat R
    Eur J Neurosci; 2019 Sep; 50(5):2905-2920. PubMed ID: 30825351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroencephalographic biomarkers as predictors of methylphenidate response in attention-deficit/hyperactivity disorder.
    Arns M; Vollebregt MA; Palmer D; Spooner C; Gordon E; Kohn M; Clarke S; Elliott GR; Buitelaar JK
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):881-891. PubMed ID: 29937325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.